SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Library > White / Technical Paper

Orphan Drugs make all the difference to patients

Format: PDF file | Document type: White / Technical Paper
Related applications: Facilities

Orphan drugs, those medications that are typically produced in small quantities for limited patient populations, are growing in importance worldwide. Once largely considered too costly to produce, given the limited number of patients affected by a particular disease, new technology and new breakthroughs in biopharma have changed the landscape, allowing more orphan drugs to be produced, thus saving countless lives that would otherwise be lost.  But bringing an orphan drug to market has its own unique set of challenges. World Courier addresses the considerations that must be overcome. 

LATEST CONTENT FROM World Courier

World Courier shares its insights on successful importation of clinical trial drugs into China

Getting a clinical trial drug into China is a complex business. Any discrepancies in paperwork or the physical shipment can lead to delays at customs or China Inspection & Quarantine. World Courier shares its experience for successful shipping.

Discover what makes South Africa uniquely placed for running clinical trials in Africa

Down at the base of Africa is a country with amazing heritage, unique geography, and challenging patient populations. See why clinical trials happen in South Africa here

World Courier discusses how healthcare, supply chain and public safety are inextricably linked

In globalising the pharmaceutical industry oversight and control has increasingly become a challenge in managing product quality, consumer safety and organisational risk.

World Courier discusses strategies for ensuring a successful supply chain

Once deficiencies in the supply chain are identified, how can the pharmaceutical industry ensure it manages product quality, consumer safety and organizational risk?

Clinical trials: World Courier explores opportunities in Southeast Asia

Southeast Asia is a growing pharmaceutical market, with a population of 620 million. What opportunities are there for multinational companies to access this rich area?

Supplier's Info Centre

World Courier